| Sanjay Kalra, MD | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Sanjay Kalra |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 43 Years |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407836422 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 38626 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital Rochester | Rochester, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic | 6507778255 | 4232 |
News Archive
Cancer Research UK and its commercial arm, Cancer Research Technology ("CRT"), are to join forces with Astellas Pharma Inc. (Tokyo, President & CEO: Yoshihiko Hatanaka, "Astellas") to find new drug targets in the fight against cancer, with an initial focus on pancreatic cancer.
By all accounts, Republicans have, so far, offered almost no specifics. They claim that they're willing to raise $800 billion in revenue by closing loopholes, but they refuse to specify which loopholes they would close; they are demanding large cuts in spending, but the specific cuts they have been willing to lay out wouldn't come close to delivering the savings they demand. It's a very peculiar situation.
Scientists from the UC Medical Center played a key role in developing what may prove to be the first effective treatment for brain hemorrhage caused by stroke.
A major challenge of systems biology is understanding how phenomena at the cellular scale correlate with activity at the organism level. A concerted effort has been made especially in the brain, as scientists are aiming to clarify how neural activity is translated into consciousness and other complex brain activities.
Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Provider Engagement solution, a dynamic tool that helps improve operational efficiency for health plans and hospitals, and positions health plans to successfully participate in the Affordable Care Act's permanent risk adjustment program for qualified health plans' individual and small group members, both inside and outside health insurance exchanges.
› Verified 3 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
Cancer Research UK and its commercial arm, Cancer Research Technology ("CRT"), are to join forces with Astellas Pharma Inc. (Tokyo, President & CEO: Yoshihiko Hatanaka, "Astellas") to find new drug targets in the fight against cancer, with an initial focus on pancreatic cancer.
By all accounts, Republicans have, so far, offered almost no specifics. They claim that they're willing to raise $800 billion in revenue by closing loopholes, but they refuse to specify which loopholes they would close; they are demanding large cuts in spending, but the specific cuts they have been willing to lay out wouldn't come close to delivering the savings they demand. It's a very peculiar situation.
Scientists from the UC Medical Center played a key role in developing what may prove to be the first effective treatment for brain hemorrhage caused by stroke.
A major challenge of systems biology is understanding how phenomena at the cellular scale correlate with activity at the organism level. A concerted effort has been made especially in the brain, as scientists are aiming to clarify how neural activity is translated into consciousness and other complex brain activities.
Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Provider Engagement solution, a dynamic tool that helps improve operational efficiency for health plans and hospitals, and positions health plans to successfully participate in the Affordable Care Act's permanent risk adjustment program for qualified health plans' individual and small group members, both inside and outside health insurance exchanges.
› Verified 3 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
Cancer Research UK and its commercial arm, Cancer Research Technology ("CRT"), are to join forces with Astellas Pharma Inc. (Tokyo, President & CEO: Yoshihiko Hatanaka, "Astellas") to find new drug targets in the fight against cancer, with an initial focus on pancreatic cancer.
By all accounts, Republicans have, so far, offered almost no specifics. They claim that they're willing to raise $800 billion in revenue by closing loopholes, but they refuse to specify which loopholes they would close; they are demanding large cuts in spending, but the specific cuts they have been willing to lay out wouldn't come close to delivering the savings they demand. It's a very peculiar situation.
Scientists from the UC Medical Center played a key role in developing what may prove to be the first effective treatment for brain hemorrhage caused by stroke.
A major challenge of systems biology is understanding how phenomena at the cellular scale correlate with activity at the organism level. A concerted effort has been made especially in the brain, as scientists are aiming to clarify how neural activity is translated into consciousness and other complex brain activities.
Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Provider Engagement solution, a dynamic tool that helps improve operational efficiency for health plans and hospitals, and positions health plans to successfully participate in the Affordable Care Act's permanent risk adjustment program for qualified health plans' individual and small group members, both inside and outside health insurance exchanges.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sanjay Kalra, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Sanjay Kalra, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
Cancer Research UK and its commercial arm, Cancer Research Technology ("CRT"), are to join forces with Astellas Pharma Inc. (Tokyo, President & CEO: Yoshihiko Hatanaka, "Astellas") to find new drug targets in the fight against cancer, with an initial focus on pancreatic cancer.
By all accounts, Republicans have, so far, offered almost no specifics. They claim that they're willing to raise $800 billion in revenue by closing loopholes, but they refuse to specify which loopholes they would close; they are demanding large cuts in spending, but the specific cuts they have been willing to lay out wouldn't come close to delivering the savings they demand. It's a very peculiar situation.
Scientists from the UC Medical Center played a key role in developing what may prove to be the first effective treatment for brain hemorrhage caused by stroke.
A major challenge of systems biology is understanding how phenomena at the cellular scale correlate with activity at the organism level. A concerted effort has been made especially in the brain, as scientists are aiming to clarify how neural activity is translated into consciousness and other complex brain activities.
Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Provider Engagement solution, a dynamic tool that helps improve operational efficiency for health plans and hospitals, and positions health plans to successfully participate in the Affordable Care Act's permanent risk adjustment program for qualified health plans' individual and small group members, both inside and outside health insurance exchanges.
› Verified 3 days ago
Emily Leasure, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Jorge A Velosa, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michael Ruediger Mueller, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mr. Karun Singh Badwal, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michal Reid, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Katherine Desprez Wick, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Allison Bock, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |